Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein SIX6OS1 (encoded by the SIX6OS1 or C14orf39 gene) is a meiosis-specific structural protein that constitutes part of the central element of the synaptonemal complex, a zipper-like protein scaffold necessary for proper pairing and synapsis of homologous chromosomes during meiotic prophase I. SIX6OS1 interacts specifically with SYCE1, another central element protein, and is essential for the appropriate progression of meiotic recombination as well as for fertility in both sexes. Mutations or loss of function in SIX6OS1 lead to defects in chromosome synapsis, meiotic arrest, and resultant infertility (both non-obstructive azoospermia and primary ovarian insufficiency). Additionally, certain genetic variants in SIX6OS1/C14orf39 influence human recombination rates, notably exhibiting sexual dimorphism in this effect[1][2][3]. SIX6OS1 is not a typical drug target receptor, enzyme, or transporter, but rather a structural meiotic protein, and no known drugs or biomarkers targeting it exist for therapeutic or diagnostic use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein SIX6OS1 (SIX6OS1).